Search Results 401-410 of 16647 for quinine

  1. Mayo Clinic

    ... . IMG-20076272. Home; PR00139Babysheart. 3X your impact! Give Now! Your gift can go 3X as far to shape the future of cancer care.

  2. Clinical trials - Oncology (Medical)

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  3. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

  4. News - Paul E. Croarkin, D.O., M.S. - Mayo Clinic

    Search for a doctor. Paul E. Croarkin, D.O., M.S.. Psychiatrist. Request an Appointment · Overview · News · Publications. News.

  5. Publications - Meghan R. Cain, M.D. - Mayo Clinic

    Fogelson EC, Klinger JA, Cain M, Mullan AF, Nestler DM, Bellolio F, Walker LE. Utilization of emergency medicine telehealth support for pediatric patients ...

  6. Hydrocodone, chlorpheniramine, and pseudoephedrine (oral route) - Side effects & dosage - Mayo Clinic

    Hydrocodone, chlorpheniramine, and pseudoephedrine combination is used to relieve cough and nasal congestion associated with the common cold allergy.

  7. John M. Sheele, M.D., M.H.S., M.P.H. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher John M. Sheele, M.D., M.H.S., M.P.H., is an emergency medicine doctor who studies infectious diseases, global health and wilderness ...

  8. Publications - Connor Q. O'Hare, M.D. - Mayo Clinic

    Joyce E, O'Hare C, Gavrila V, Cuttitta A, Greineder C, Barnes GD. Performance of an Electronic Health Record-based automated Pulmonary Embolism Severity Index ...

  9. ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection - Mayo Clinic

    About this study. Subjects will receive an oral dose of SER-109 in 4 capsules once daily for 3 consecutive days in Treatment Group I or matching placebo ...

  10. Mayo Clinic

    Don't miss your chance! · About Mayo Clinic · Medical Professionals · Businesses · Students · Researchers · International Patients · Charitable Care & Financial ...